• Top Videos
• Top Searches

Shuren Fda

What is CDRH doing to accelerate the regulatory pathway for innovative medical technologies?

6:16 |

FDA official testifies regarding laboratory developed tests (LDTs)

4:02 |

EP. 2 Jeffrey Shuren on FDA-sponsor interactions: Where they’ve been and where they’re going

29:01 |

Jeffrey Shuren, director of FDA's CDRH will make end year (2011) announcement on amalgam rule

4:36 |

Total Product Lifecycle Advisory Program (TAP) Engagement with Device Developers

4:16 |

MDUFA IV and Beyond: Video Reports

9:24 |

Did FDA's Jeffrey Shuren lie under oath about Google-backed 23andMe?

4:58 |

CDRH Center Director Jeff Shuren on why FDA invests in MDIC

0:56 |

Jeff Shuren of the FDA at the 2023 Utah Life Sciences Summit

45:24 |

US FDA CDRH Director Jeff Shuren presents at the MDIC 2015 Annual Public Forum

10:51 |

Reporting on MassMEDIC's Regulatory Roundup

7:32 |

Conversation with Dr. Jeff Shuren

48:09 |

FDA Roundtable

48:31 |

07/18/2018 - Session VI: Shuren

13:41 |

What's most important for innovators to understand about FDA's new mobile health guideline?

3:01 |

Medtech Insight interviews CDRH Director Jeff Shuren

15:15 |

FDA Town Hall from the 2024 Utah Life Sciences Summit

44:23 |

Indiana CTSI Winter Retreat: Keynote Q&A with Dr. Jeffrey E. Shuren, MD, JD

1:03:42 |

Safety Signal Transparency: Using the Power of Data

34:48 |

Closing Keynote: CDRH Updates

28:50 |